Concepedia

Author

Toshihide Shibazaki

Kissei Pharmaceutical (Japan)

Also Known As

T. Shibazaki, Toshihide Shibazaki

14

Publications

204

Citations

8

H-Index

24

Concepts

All Affiliations

Kissei Pharmaceutical (Japan)Shinshu UniversityIwate Medical UniversityInstitute on AgingTokyo University of Science
TS

About

Toshihide Shibazaki is an author at Kissei Pharmaceutical (Japan) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

59

2

Biochemistry

2

2

34

3

Health Sciences

1

1

15

4

Natural Sciences

1

1

15

5

Diabetes

1

1

19

Toshihide Shibazaki

×

8

Publications

203

Citations

8

H-Index

YearCitations

KGA-2727, a Novel Selective Inhibitor of a High-Affinity Sodium Glucose Cotransporter (SGLT1), Exhibits Antidiabetic Efficacy in Rodent Models

Toshihide Shibazaki, Masaki Tomae, Yukiko Ishikawa-Takemura,

Journal of Pharmacology and Experimental Therapeutics

2012

81

Decrease in the density of t-tubular L-type Ca<sup>2+</sup> channel currents in failing ventricular myocytes

Miwa Horiuchi‐Hirose, Toshihide Kashihara, Tsutomu Nakada,

American Journal of Physiology-Heart and Circulatory Physiology

2010

39

Structure–activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia

Nobuhiko Fushimi, Hideki Fujikura, Hiroaki Shiohara,

Bioorganic & Medicinal Chemistry

2012

19

Phlorizin Prevents Electrically-Induced Ventricular Tachyarrhythmia during Ischemia in Langendorff-Perfused Guinea-Pig Hearts

Masamichi Hirose, Toshihide Shibazaki, Tsutomu Nakada,

Biological and Pharmaceutical Bulletin

2014

15

Design, synthesis, and structure–activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl β-d-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1)

Nobuhiko Fushimi, Hirotaka Teranishi, Kazuo Shimizu,

Bioorganic & Medicinal Chemistry

2012

15

Chronic receptor-mediated activation of G<sub>i/o</sub>proteins alters basal t-tubular and sarcolemmal L-type Ca<sup>2+</sup>channel activity through phosphatases in heart failure

Toshihide Kashihara, Tsutomu Nakada, Hisashi Shimojo,

American Journal of Physiology-Heart and Circulatory Physiology

2012

14

The proximal C-terminus of α1C subunits is necessary for junctional membrane targeting of cardiac L-type calcium channels

Tsutomu Nakada, Bernhard E. Flucher, Toshihide Kashihara,

Biochemical Journal

2012

10

Two mechanistically distinct effects of dihydropyridine nifedipine on CaV1.2 L-type Ca2+ channels revealed by Timothy syndrome mutation

Xiaona Sheng, Tsutomu Nakada, Motohiro Kobayashi,

European Journal of Pharmacology

2012

10

Page 1